Finance

Lists
Why is CWY1 down 100.00%?
Dive Deeper
CWY1:FRA
Clearmind Medicine Inc
-100.00%
(-5.12) 1D
Oct 7, 7:00:03 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CWY1...
Mkt. cap
2.82M
Volume
0.00
52-wk high
€21.55
52-wk low
€3.46
Mkt. cap
2.82M
Volume
0.00
52-wk high
€21.55
52-wk low
€3.46
News stories
From web sources and news partners
About Clearmind Medicine Inc
CEO-
Employees-
Founded2017
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
420.18K
640.49K
646.71K
588.96K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.04M
3.02M
924.50K
1.59M
Operating expense
1.46M
3.66M
1.57M
2.18M
Total operating expenses
1.46M
3.66M
1.57M
2.18M
Operating income
-1.46M
-3.66M
-1.57M
-2.18M
Other non operating income
-190.50K
365.93K
-452.44K
582.57K
EBT including unusual items
-685.65K
-3.85M
-2.04M
-904.06K
EBT excluding unusual items
-1.61M
-3.23M
-1.98M
-1.51M
Income tax expense
2.19K
3.96K
3.31K
3.23K
Effective tax rate
-0.32%
-0.10%
-0.16%
-0.36%
Other operating expenses
-
-
-
-
Net income
-687.84K
-3.85M
-2.05M
-907.29K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
30.90K
64.65K
42.02K
106.96K
Interest expense
-
-4.11K
-4.23K
-5.31K
Net interest expenses
30.90K
60.54K
37.79K
101.66K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.45M
-3.66M
-1.57M
-2.18M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps